MicroRNA-135 Inhibits Initiation of Epithelial-Mesenchymal Transition in Breast Cancer by Targeting ZNF217 and Promoting m6A Modification of NANOG

Scientists highlighted the role of the miR-135/zinc finger protein 217 (ZNF217)/methyltransferase-like 13/NANOG axis in the progression of breast cancer (BC), emphasizing potential therapeutic targets ZNF217 silencing and miR-135 upregulation in preventing or treating BC.